CARDIOEMBOLIC STROKE IN LATVIA : PREVENTION AND LONG-TERM OUTCOME

Simple item page
dc.contributor.authorPucite, Elina
dc.contributor.authorJurjans, Kristaps
dc.contributor.authorMiglane, Evija
dc.contributor.authorLurina, Baiba
dc.contributor.authorKalējs, Oskars
dc.contributor.authorMillers, Andrejs
dc.contributor.authorPriede, Zanda
dc.contributor.institutionDepartment of Neurology and Neurosurgery
dc.contributor.institutionDepartment of Internal Diseases
dc.coverage.spatialPrague
dc.date.accessioned2021-08-19T08:55:01Z
dc.date.available2021-08-19T08:55:01Z
dc.date.issued2016
dc.description.abstractNTRODUCTION:Untreated non-valvular atrial fibrillation is one of major causes of stroke. The goalof the study was to evaluate the use of antithrombotic medication stroke prevention and assess long-term stroke outcome.METHODS:This study involved 531 cardio embolicstroke patients of thePaul’sStradins Clinical University Hospital, Riga, Latvia,in 2014. After dischargethe patients or their relatives were interviewed by phone after 30, 90, 180, and 365 days. Standardized questions were asked about the patients’abilities and use of prescribed secondary prevention medication. Theresults were compared between patient groups, assigned according to prescribed medications. RESULTS:Of all the patients included in the study,8.9% were using oral anticoagulants before stroke onset. One year after discharge,1.44% of patients were not using any preventivemedication, 23.56%were using antiplatelet agents, 43.27% warfarin,and 31.73% target-specificoralanticoagulants. The one-year mortality ratewas 40.7%. The mortality rate was significantly higher in the patient group using no secondary preventivemedication or antiplatelet agents compared to the patient group that used oral anticoagulants. CONCLUSION:Cardio embolicstroke primary and secondary prevention in Latvia islacking. The study outcomes suggest that action is neededto increase the use of oral anticoagulants in primary stroke prevention in patients with atrial fibrillation. Poor function outcomes, dementia,and patients’incompliance limits the use of oral anticoagulants in secondary preventionen
dc.description.statusPeer reviewed
dc.format.extent451574
dc.identifier.citationPucite, E, Jurjans, K, Miglane, E, Lurina, B, Kalējs, O, Millers, A & Priede, Z 2016, CARDIOEMBOLIC STROKE IN LATVIA : PREVENTION AND LONG-TERM OUTCOME. in CBU International Conference on Integration and Innovation in Science and Education : proceedings. vol. 4, CBU INTERNATIONAL CONFERENCE PROCEEDINGS 2016: INNOVATIONS IN SCIENCE AND EDUCATION, Central Bohemia University, Prague, pp. 615-621, CBU International Conference on Innovations in Science and Education , Prague, Czech Republic, 23/06/16. https://doi.org/10.12955/cbup.v4.821
dc.identifier.citationconference
dc.identifier.doi10.12955/cbup.v4.821
dc.identifier.isbn978-80-88042-04-4
dc.identifier.issn1805-997X
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/6047
dc.language.isoeng
dc.publisherCentral Bohemia University
dc.relation.ispartofCBU International Conference on Integration and Innovation in Science and Education
dc.relation.ispartofseriesCBU INTERNATIONAL CONFERENCE PROCEEDINGS 2016: INNOVATIONS IN SCIENCE AND EDUCATION
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAtrial fibrillation
dc.subjectcardio embolic stroke
dc.subjectstroke mortality
dc.subjectprimary stroke prevention
dc.subjectsecondary stroke prevention
dc.subject3.2 Clinical medicine
dc.subject3.1. Articles or chapters in proceedings/scientific books indexed in Web of Science and/or Scopus database
dc.titleCARDIOEMBOLIC STROKE IN LATVIA : PREVENTION AND LONG-TERM OUTCOMEen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontobookanthology/conference

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
CARDIOEMBOLIC_STROKEIN_LATVIA.pdf
Size:
440.99 KB
Format:
Adobe Portable Document Format
Download

Collections

Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure